Inicio › Cáncer de pulmón › Illinois › Joliet
Ensayos clínicos de Cáncer de pulmón en Joliet, IL
12 estudios para Cáncer de pulmón buscan participantes en centros de Joliet y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · A 6 mi de distancia
- University of Chicago Medicine-Orland Park, Orland Park · A 14 mi de distancia
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ReclutandoFase 3
- Northwestern Medicine Orland Park, Orland Park · A 14 mi de distancia
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- Northwestern Medicine Orland Park, Orland Park · A 14 mi de distancia
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
ReclutandoFase 2
- Hope and Healing Clinical Research, New Lenox · A 6 mi de distancia
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- Hope and Healing Cancer Services, New Lenox · A 6 mi de distancia
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
ReclutandoFase 2
- Hope and Healing Clinical Research, New Lenox · A 6 mi de distancia
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ReclutandoFase 3
- Hope and Healing Cancer Services, New Lenox · A 6 mi de distancia
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
ReclutandoFase 1/2
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · A 6 mi de distancia
- University of Chicago Medicine-Orland Park, Orland Park · A 14 mi de distancia
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- University of Chicago, New Lenox · A 6 mi de distancia
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- Northwestern Medicine Orland Park, Orland Park · A 14 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Northwestern Medicine Orland Park, Orland Park · A 14 mi de distancia
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- Northwestern Medicine Orland Park, Orland Park · A 14 mi de distancia
Más información sobre Cáncer de pulmón en MedlinePlus
Ensayos de Cáncer de pulmón en otras ciudades
- Houston, TX78 estudios
- Boston, MA62 estudios
- New York City, NY60 estudios
- Los Angeles, CA45 estudios
- Washington, DC41 estudios
- Arlington, VA41 estudios
- Chicago, IL41 estudios
- Nashville, TN40 estudios
- Baltimore, MD40 estudios
- St. Louis, MO39 estudios
- Columbus, OH37 estudios
- Philadelphia, PA36 estudios
Otros estudios en Joliet
- Cáncer de pulmón de células no pequeñas12 estudios
- Cáncer metastásico7 estudios
- Cáncer de vejiga7 estudios
- Carcinoma de células escamosas de cabeza y cuello6 estudios
- Cáncer de próstata5 estudios
- Cáncer hipofaríngeo5 estudios
- Cáncer de laringe5 estudios
- Cáncer oral5 estudios
- Leucemia mielógena aguda5 estudios
- Cáncer de seno4 estudios
- Cáncer de colon4 estudios
- Cáncer de riñón (carcinoma de células renales)4 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.